MicroRNA-26a inhibits osteosarcoma cell proliferation by targeting IGF-1

There are still controversies about the roles of microRNA-26a（miR-26a）in human malignancies,as it is a tumor suppressor in breast cancer,gastric cancer,and hepatocellular carcinoma,but is an oncogene in glioma and cholangiocarcinoma.Until now,the function of miR-26a in osteosarcoma remains largely elusive.Here,we found that miR-26a was downregualted in osteosarcoma tissues.Using in vitro and in vivo assays,we confirmed that miR-26a could inhibit the abilities of in vitro proliferation and suppress in vivo tumor growth in mouse model.Furthermore,we identified insulin-like growth factor 1（IGF-1）as a novel and direct target of miR-26a and revealed that miR-26a exerted its tumor-suppressor function,at least in part,by inhibiting IGF-1expression.These findings contribute to our understanding of the functions of miR-26a in osteosarcoma.

miR-148b-3p promotes migration of Schwann cells by targeting cullin-associated and neddylationdissociated 1

MicroRNAs（miRNAs） are small,non-coding RNAs that negatively adjust gene expression in multifarious biological processes.However,the regulatory effects of miRNAs on Schwann cells remain poorly understood.Previous microarray analysis results have shown that miRNA expression is altered following sciatic nerve transaction,thereby affecting proliferation and migration of Schwann cells.This study investigated whether miR-148b-3p could regulate migration of Schwann cells by directly targeting cullin-associated and neddylation-dissociated 1（Cand1）.Up-regulated expression of miR-148b-3p promoted Schwann cell migration,whereas silencing of miR-148b-3p inhibited Schwann cell migration in vitro.Further experiments confirmed that Candl was a direct target of miR-148b-3p,and Candl knockdown reversed suppression of the miR-148b-3p inhibitor on Schwann cell migration.These results suggested that miR-148b-3p promoted migration of Schwann cells by directly targeting Candl in vitro.

ARBs improve stroke outcome through an AT2-dependent, BDNF-induced proangiogenic and prorecovery response

Preclinical stroke research has introduced a number of potential interventions that can be utilized to enhance recovery after stroke（Lo and Rosenberg,2009）.

Uncovering the mystery of Ebola virus entry: Lock and key

How Ebola virus(EBOV)enters a host cell remains intriguingly mysterious to the public.Recently,a study led by George F Gao and his colleagues has unveiled how the primed glycoprotein on the envelope of EBOV binds to its endosomal receptor Niemann-Pick C1(NPC1)molecule during the process of virus membrane fusion with the host cells,an essential step for viral entry(Wang et al.,2016).This fine resolution of the viral glycoprotein with NPC1 at the atomic level sheds light on the development of therapeutic inhibitors against EBOV infection.

Natural small-molecule sappanone A selectively targets IMPDH2 to inhibit neuroinflammation

With the support by the National Natural Science Foundation of China,a study by the research group led by Prof.Tu Pengfei(屠鹏飞)from the School of Pharmaceutical Sciences,Peking University demonstrates that natural small-molecule sappanone A directly targets IMPDH2to block its activity,

Targeted suppression of miRNA-21 inhibit K562 cells growth through PTEN-PI3K/AKT signaling pathway

Objective To investigate the K562 cells biological function and related molecular changes in PTEN-PI3K/AKT signaling pathway of leukemia K562 cells by inhibiting the miRNA-21 expression to explore its pathogenesis of leukemia.Methods The chemical synthetic miRNA-